Skip to content

Outcomes of Definitive Radiotherapy for Bladder Cancer

Outcomes of Definitive Radiotherapy for Bladder Cancer: Real-World Experience From a Single Center

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07503795
Enrollment
300
Registered
2026-03-31
Start date
2026-04-01
Completion date
2027-06-01
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer (BC)

Brief summary

this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer

Interventions

it is observational study for patient recieved defentive radiotherapy

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy

Exclusion criteria

* Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.

Design outcomes

Primary

MeasureTime frame
overall survival, it is defined as time from initiation of treatment till death due to any cause or last date for follow upone and two year
bladder intact events free survival , which is the time from initiation of radical ttt till occurrence of bladder recurrenceone and two year
disease free survival , it is time from starting radical ttt till occurrance of 1st recurrence or distant metastasisone and two years

Secondary

MeasureTime frame
adverse events , it is treatment related toxicity and side effectsone year

Countries

Egypt

Contacts

CONTACTheba elsagheer
hebaelsagheer@yahoo.com0201062162612

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026